A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer

A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer

Abstract Introduction Bevacizumab and gemcitabine are key drugs for treating recurrent epithelial ovarian cancer. However, information about the combination of bevacizumab and gemcitabine is insufficient. We conducted a phase II study to assess the feasibility, clinical activity, and toxicity of thi...

Full description

Saved in:
Bibliographic Details
Main Authors: Shoji Nagao (Author), Ai Kogiku (Author), Kazuhiro Suzuki (Author), Takashi Shibutani (Author), Kasumi Yamamoto (Author), Tomoatsu Jimi (Author), Miho Kitai (Author), Takaya Shiozaki (Author), Kazuko Matsuoka (Author), Satoshi Yamaguchi (Author)
Format: Book
Published: BMC, 2020-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items